SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH -- Ignore unavailable to you. Want to Upgrade?

To: Hanney Yin who wrote (626)4/3/1998 11:07:00 PM
From: Craig Ferguson  Respond to of 998
 
Just like CORR, on April 9th the decision will be made whether or not to recommend to the FDA that they approve or disaprove the drug. It's sort of like a foregone conclusion that if Myotrophin gets approval April 9th, the FDA will rubber stamp the recomondation in May, thus April is the big day. Price would pop a teeny bit in May as well, but not as much.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News